Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine and Candesartan Combination in Essential Hypertension
NCT02368665Phase 3Completed
- Sponsor
- HK inno.N Corporation
- Start
- Dec 2014
- Primary completion
- Nov 2015
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amlodipine, candesartan cilexetil in essential hypertension, sponsored by HK inno.N Corporation. Started Dec 2014; status: completed.
02
Drugs
amlodipinecandesartan cilexetil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02368665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368665.